|
Dr. Milligan joined Gilead Sciences in 1990 as a research scientist and was made Director of Project Management and Project Team Leader for the Gilead Hoffman-La Roche Tamilfu® collaboration in 1996. In 2003 Dr. Milligan was appointed Chief Financial Officer and was made Chief Operating Officer in 2007.
Dr. Milligan received his PhD in biochemistry from the University of Illinois and was an American Cancer Society postdoctoral fellow at the University of California at San Francisco. Dr. Milligan was named Bay Area CFO of the Year in 2006 for companies with revenues greater than $500 million and he was named the top biotechnology industry CFO in the United States by Institutional Investor magazine in 2007 and 2006.
| 